US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PURE Bioscience

0.0820

+0.00030.37%

Volume:20.15K

Turnover:1.66K

Market Cap:9.17M

PE:-4.25

High:0.0829

Open:0.0829

Low:0.0820

Close:0.0817

52wk High:0.2136

52wk Low:0.0386

Shares:111.89M

Float Shares:65.71M

Volume Ratio:0.31

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0193

EPS(LYR):-0.0299

ROE:-977.21%

ROA:-181.90%

PB:-1.46

PE(LYR):-2.74

Loading ...

Overview Company News Filings

PURE Bioscience Q2 FY2026 net product sales rise 13% to USD 443,000

Pure Bioscience Reports Fiscal Second Quarter 2026 Financial Results

THOMSON REUTERS

Pure Bioscience, Inc. Q2 EPS USD -0.01

THOMSON REUTERS

Vintage Energy extends PURE loan to 2028 to back Southern Flank gas push

PURE Biosciences Inc. Held Annual Stockholders Meeting

Press Release: PURE Property Management and HomeRiver Group Merge, Secure $80 Million in Growth Capital

PURE Bioscience Inc. Announces Date for Upcoming Annual Stockholders Meeting

Antimicrobial products maker PURE Bioscience's Q1 net loss narrows

PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY

PURE Bioscience Q1 net loss narrows to USD 464,000 as revenue rises 27% to USD 708,000

Pure Bioscience, Inc. Q1 EPS USD 0

THOMSON REUTERS

PURE Biosciences Inc. Files Initial Beneficial Ownership Statement for President and Corporate Secretary Jeffrey Scott Kitchell

BRIEF-Pure Bioscience, Inc. Announces Leadership Promotions

PURE Biosciences Names Jeff Kitchell President and Dolana Blount VP of Operations

Iinnofashion Accelerates Global Expansion with K-Beauty Brand 'IINNO PURE COSME'

PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY

Press Release: PURE Bioscience Reports Fiscal 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PURE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PURE\",,,,,undefined,":{"symbol":"PURE","market":"US","secType":"STK","nameCN":"PURE Bioscience","latestPrice":0.082,"timestamp":1774036800000,"preClose":0.0817,"halted":0,"volume":20150,"delay":15,"changeRate":0.0036719706242351116,"floatShares":65708474,"shares":111886473,"eps":-0.019315,"marketStatus":"Pre-Mkt","change":0.0003,"latestTime":"03-20 16:00:00 EDT Delay","open":0.0829,"high":0.0829,"low":0.082,"amount":1661.3863999999999,"amplitude":0.011016,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.019315,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774272600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.082,"volumeRatio":0.3108963377699123},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PURE\",,,,,undefined,":{"symbol":"PURE","floatShares":65708474,"roa":"-181.90%","roe":"-977.21%","lyrEps":-0.029949,"volumeRatio":0.3108963377699123,"shares":111886473,"dividePrice":0,"high":0.0829,"amplitude":0.011016,"preClose":0.0817,"low":0.082,"week52Low":0.0386,"pbRate":"-1.46","psRate":"3.81","week52High":0.2136,"institutionHeld":0,"latestPrice":0.082,"eps":-0.019315,"divideRate":0,"volume":20150,"delay":15,"ttmEps":-0.019315,"open":0.0829,"prevYearClose":0.042,"prevWeekClose":0.0785,"prevMonthClose":0.0605,"prevQuarterClose":0.042,"fiveDayClose":0.0785,"twentyDayClose":0.0567,"sixtyDayClose":0.0463},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PURE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-03-18","symbol":"PURE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-12-14","symbol":"PURE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1702530000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-10-30","symbol":"PURE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1698638400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-06-14","symbol":"PURE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1686715200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-12-14","symbol":"PURE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1670994000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PURE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PURE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620499512","title":"PURE Bioscience Q2 FY2026 net product sales rise 13% to USD 443,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2620499512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620499512?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:05","pubTimestamp":1773691541,"startTime":"0","endTime":"0","summary":"PURE Bioscience published a fiscal second-quarter 2026 financial results press release. In Q2 FY2026, net product sales rose 13.3% to USD 443,000, attributed to increased sales across its end-user network. Net loss in Q2 FY2026 was USD 0.79 million and net loss excluding share-based compensation was USD 727,000. For the six months ended Jan. 31, 2026, net product sales rose 21.6% to USD 1.15 million, while net loss narrowed 16% to USD 1.25 million on lower selling, general and administrative expenses, partly offset by higher interest expense tied to notes payable. PURE said it received USDA Biobased Product Certification for PURE Clean and expects to launch the product and fulfill pre-orders in fiscal Q3, while also pursuing new dairy applications, a dairy-farmer marketing campaign, and biomedical opportunities with Quip Laboratories.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLb3wLyN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4018","PURE"],"gpt_icon":0},{"id":"2620499317","title":"Pure Bioscience Reports Fiscal Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620499317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620499317?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:05","pubTimestamp":1773691501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUA2KZXJV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4018","PURE"],"gpt_icon":0},{"id":"2620995514","title":"Pure Bioscience, Inc. Q2 EPS USD -0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2620995514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620995514?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:05","pubTimestamp":1773691501,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nPLX487AA0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2616303311","title":"Vintage Energy extends PURE loan to 2028 to back Southern Flank gas push","url":"https://stock-news.laohu8.com/highlight/detail?id=2616303311","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616303311?lang=en_us&edition=fundamental","pubTime":"2026-03-04 07:54","pubTimestamp":1772582063,"startTime":"0","endTime":"0","summary":"Vintage Energy Ltd. ( ($AU:VEN) ) just unveiled an announcement. Vintage Energy has extended and amended its $10 million secured loan facility with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vintage-energy-extends-pure-loan-to-2028-to-back-southern-flank-gas-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vintage-energy-extends-pure-loan-to-2028-to-back-southern-flank-gas-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BMG7P819.SGD","LU0211328371.USD","LU1929549753.HKD","IE00BMG7P694.USD","LU2384288077.EUR","LU1621768115.EUR","BK4588","LU1621767737.EUR","PURE","LU0320765646.SGD","LU1162221912.USD","LU1267930490.SGD","LU2347655073.USD","BK4081","IE00B29SXK94.USD","LU0726765562.USD","LU0070217475.USD","LU1732800096.USD","LU0795875086.SGD","LU0098860793.USD","LU0795875169.SGD","IE00BMG7P926.USD","LU1718418525.SGD","LU0211327993.USD","LU1621768206.USD","BK4585","LU2133065610.SGD","LU0310799852.SGD","SO","LU2347655156.SGD","LU1732799900.SGD","IE00BMG7P587.USD","LU1621767810.EUR","IE00B29SXL02.USD","LU0912757837.SGD","BK4018"],"gpt_icon":0},{"id":"2613290694","title":"PURE Biosciences Inc. Held Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290694","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290694?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:50","pubTimestamp":1771624220,"startTime":"0","endTime":"0","summary":"PURE Biosciences Inc. held an annual meeting of stockholders on Feb. 17, 2026. Stockholders approved the slate of director nominees, ratified the appointment of Weinberg & Company, P.A. as independent auditor for the fiscal year ending July 31, 2026, and approved an amendment to the certificate of incorporation to increase the authorized number of common shares to 250 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL4FjCQt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4018","PURE"],"gpt_icon":0},{"id":"2605046092","title":"Press Release: PURE Property Management and HomeRiver Group Merge, Secure $80 Million in Growth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605046092","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605046092?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:00","pubTimestamp":1769079600,"startTime":"0","endTime":"0","summary":"PURE HomeRiver will operate as the nation's largest third-party single-family rental  property management company. LOS GATOS, Calif., Jan. 22, 2026 /PRNewswire/ -- PURE Property Management and HomeRiver Group today announced their merger, operating as PURE HomeRiver. Combined, PURE HomeRiver manages over 40,000 properties across 80+ local offices in 200+ markets and adjacent cities across 35+ states, with the vision of making renting and investing simple, smart, and more satisfying.Local teams are the heart of PURE HomeRiver, and the company is committed to further expanding its network of hands-on, in-market professionals. For current clients and residents, nothing changes today. Services continue as-is, points of contact remain the same, and portals and agreements stay in place as the companies integrate the best of both organizations in the background.The PURE HomeRiver platform combines PURE's AI-native technology and unified operations with HomeRiver's national footprint and insti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PURE","PFI","BK4588","BK4162","CFA.SI","PRU","BK4018"],"gpt_icon":0},{"id":"2592544184","title":"PURE Bioscience Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592544184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592544184?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:32","pubTimestamp":1766093528,"startTime":"0","endTime":"0","summary":"PURE Bioscience, Inc. will hold its 2026 annual meeting of stockholders on February 17, 2026, at SpringHill Suites Huntington Beach Orange County.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL7c0h4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4018","PURE"],"gpt_icon":0},{"id":"2591624957","title":"Antimicrobial products maker PURE Bioscience's Q1 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624957?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:20","pubTimestamp":1765833620,"startTime":"0","endTime":"0","summary":"Antimicrobial products maker PURE Bioscience's Q1 net loss narrowsOverviewAntimicrobial solutions firm's fiscal Q1 net product sales rose, driven by customer base growthFiscal Q1 net loss decreased co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL1N3XL0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2591248156","title":"PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2591248156","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591248156?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:11","pubTimestamp":1765833111,"startTime":"0","endTime":"0","summary":"PURE Bioscience (OTC:PURE) reported $707.000 thousand in sales this quarter. This is a 27.16 percent increase over sales of $556.000 thousand the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49406870/pure-bioscience-q1-sales-707-000k-up-from-556-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PURE Bioscience Q1 Sales $707.000K Up From $556.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE"],"gpt_icon":0},{"id":"2591262103","title":"PURE Bioscience Q1 net loss narrows to USD 464,000 as revenue rises 27% to USD 708,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2591262103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591262103?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:05","pubTimestamp":1765832743,"startTime":"0","endTime":"0","summary":"PURE Biosciences Inc. reported its financial results for the fiscal first quarter ended October 31, 2025. The company posted net product sales of USD 0.71 million for the period. Total revenue, including royalty revenue, reached USD 0.71 million. Cost of goods sold amounted to USD 0.26 million, resulting in a gross profit of USD 0.45 million. Selling, general and administrative expenses were USD 0.74 million, and research and development expenses totaled USD 0.09 million. Total operating costs and expenses were USD 0.83 million. The company reported a loss from operations of USD 0.38 million and a net loss of USD 0.46 million for the quarter. Basic and diluted net loss per share was USD 0.00, with 111,886,473 shares used in the calculation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL9dHbFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2591621751","title":"Pure Bioscience, Inc. Q1 EPS USD 0","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621751?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:05","pubTimestamp":1765832701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nPLX5CDA96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2587079758","title":"PURE Biosciences Inc. Files Initial Beneficial Ownership Statement for President and Corporate Secretary Jeffrey Scott Kitchell","url":"https://stock-news.laohu8.com/highlight/detail?id=2587079758","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587079758?lang=en_us&edition=fundamental","pubTime":"2025-11-29 07:25","pubTimestamp":1764372338,"startTime":"0","endTime":"0","summary":"PURE Biosciences Inc. Files Initial Beneficial Ownership Statement for President and Corporate Secretary Jeffrey Scott Kitchell. PURE Biosciences Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Jeffrey Scott Kitchell as the beneficial owner, serving as President and Corporate Secretary of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 28, 2025, and is solely respons","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL46mXDt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2584097699","title":"BRIEF-Pure Bioscience, Inc. Announces Leadership Promotions","url":"https://stock-news.laohu8.com/highlight/detail?id=2584097699","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584097699?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:39","pubTimestamp":1763588353,"startTime":"0","endTime":"0","summary":"BRIEF-Pure Bioscience, Inc. Announces Leadership PromotionsNov 19 (Reuters) - PURE Biosciences Inc PURE.PK:PURE BIOSCIENCE, INC. ANNOUNCES LEADERSHIP PROMOTIONSSource text: ID:nBw8FtstNaFurther company coverage: PURE.PK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA7QMZXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2584755099","title":"PURE Biosciences Names Jeff Kitchell President and Dolana Blount VP of Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2584755099","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584755099?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:06","pubTimestamp":1763586368,"startTime":"0","endTime":"0","summary":"PURE Bioscience, Inc. has announced leadership changes effective November 17, 2025. Jeff Kitchell has been appointed President while continuing as Corporate Secretary. Dolana Blount has been named Vice President of Operations in addition to her role as Vice President of Regulatory Affairs. Robert Bartlett remains Chief Executive Officer and Board Member but will step down as President.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PURE Biosciences Inc. published the original content used to generate this news brief via Business Wire  on November 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDLXWNDk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE","BK4018"],"gpt_icon":0},{"id":"2584837609","title":"Iinnofashion Accelerates Global Expansion with K-Beauty Brand 'IINNO PURE COSME'","url":"https://stock-news.laohu8.com/highlight/detail?id=2584837609","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584837609?lang=en_us&edition=fundamental","pubTime":"2025-11-18 09:00","pubTimestamp":1763427600,"startTime":"0","endTime":"0","summary":"SEOUL, South Korea, Nov. 18, 2025 /PRNewswire/ -- Iinnofashion, a company that provides overseas distribution consulting for K-beauty brands, has launched its own private brand  'IINNO PURE COSME', accelerating its efforts to penetrate global markets with a focus on Japan, as well as Russia, China, and Southeast Asia.As a cosmetics manufacturer, Iinnofashion is expanding its global network by engaging not only in OEM and ODM production but also in overseas distribution consulting for K-cosmetic brands. In particular, its in-house brand 'IINNO PURE COSME' is currently in discussions for a collaboration with the Japanese brand ANAP, aiming to introduce its cosmetic products within ANAP's accessory segment. The brand also strengthened its position as a leading K-beauty label after being featured on LEOMAX, Russia's largest home shopping channel, where it received positive feedback from local consumers.A representative from Iinnofashion stated, \"Entering overseas markets is not just about ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/iinnofashion-accelerates-global-expansion-with-k-beauty-brand-iinno-pure-cosme-302617352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6096","BK6505","N0Z.SI","IE00B64QTZ34.USD","IE00BLDYK493.USD","PURE","BK4211","PB","BK4018"],"gpt_icon":0},{"id":"2579132764","title":"PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2579132764","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579132764?lang=en_us&edition=fundamental","pubTime":"2025-10-30 05:43","pubTimestamp":1761774189,"startTime":"0","endTime":"0","summary":"PURE Bioscience (OTC:PURE) reported $764.000 thousand in sales this quarter. This is a 61.18 percent increase over sales of $474.000 thousand the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48514468/pure-bioscience-q4-sales-764-000k-up-from-474-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PURE Bioscience Q4 Sales $764.000K Up From $474.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PURE"],"gpt_icon":0},{"id":"2579322521","title":"Press Release: PURE Bioscience Reports Fiscal 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579322521","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579322521?lang=en_us&edition=fundamental","pubTime":"2025-10-30 05:37","pubTimestamp":1761773820,"startTime":"0","endTime":"0","summary":"PURE Bioscience, Inc.  , creator of the patented non-toxic silver dihydrogen citrate  antimicrobial, today reported financial results for the fiscal year ended July 31, 2025.--  Net product sales were $2,198,000 and $1,955,000 for the fiscal years. ended July 31, 2025 and 2024, respectively. The $243,000 increase was. attributable to increased sales across our end-user and distribution. --  Net loss for the fiscal year ended July 31, 2025 was ,compared to  for the fiscal year ended July 31, 2024.During the current fiscal year, the Company significantly reduced. --  Net loss, excluding share-based compensation, for the fiscal year ended. , compared to  for the fiscal year ended July. To strengthen our reach and accelerate growth, we expanded our distribution network in the second quarter through a new agreement with Hydrite Chemical Company, a respected leader in the dairy and food processing industries. In the fourth quarter, we built on this momentum by forming a strategic partnership","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","SDC","PURE","BK4018","BK4198"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}